Radiological and pathological diagnosis of paediatric bone tumours and tumour-like lesions

Pathology

Volumn 40, Issue 2, 2008, Pages 196-216

  Vlychou, M ^a   Athanasou, N A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone tumour; Histopathology; Paediatric; Radiology; Review

Indexed keywords

AGE; ANEURYSMAL BONE CYST; ANGIOSARCOMA; BONE BIOPSY; BONE CYST; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BONE TUMOR; CHILDHOOD CANCER; CHONDROBLASTOMA; CHONDROSARCOMA; CHORDOMA; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DERMATOFIBROMA; DESMOID TUMOR; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENCHONDROMA; EWING SARCOMA; FIBROMA; FIBROSARCOMA; FIBROUS DYSPLASIA; GIANT CELL TUMOR; HAMARTOMA; HEMANGIOMA; HEMANGIOPERICYTOMA; HEREDITARY MULTIPLE EXOSTOSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MALIGNANT FIBROUS HISTIOCYTOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLASTOMA; OSTEOCLASTOMA; OSTEOID OSTEOMA; OSTEOMA; REVIEW; TUMOR LOCALIZATION;

EID: 38349051418     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701813784     Document Type: Article

References (142)

1. Souhami R. Incidence and aetiology of malignant primary bone tumours. Bailliere's Clin Oncol 1987; 1: 1-20.
2. Grimer RJ, Carter SR. Paediatric surgical oncology. 3-Bone tumours. Eur J Surg Oncol 1995; 21: 217-22.
3. Dorfman HD, Czerniak B, Kotz R, Vand D, Park YK, Unni KK. WHO classification of tumours of bone. In: Fletcher CD, Unni KK, Mertens F, editors. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002; 223-6.
4. th series. Washington, DC: Armed Forces Institute of Pathology, 2005.
5. Adler CP, Kozlowski K. Primary Bone Tumors and Tumorous Conditions in Children. London: Springer-Verlag, 1993.
6. Letson GD, Greenfield GB, Heinrich SD. Evaluation of the child with a bone or soft tissue neoplasm. Orthop Clin North Am 1996; 27: 431-51.
7. Simon MA, Finn HA. Diagnostic strategy for bone and soft tissue bone tumours. J Bone Joint Surg 1993; 7A: 622-31.
8. Coombs R, Friedlaender G. Bone Tumour Management. London: Butterworth & Co, 1987.
9. Teo HE, Peh WC. The role of imaging in the staging and treatment planning of primary malignant bone tumors in children. Eur Radiol 2004; 14: 465-75.
10. Fenoy AJ, Greenlee JD, Menezes AH, et al. Primary bone tumors of the spine in children. J Neurosurg 2006; 105 (Suppl): 252-60.
11. Fayad LM, Bluemke DA, Weber KL, Fishman EK. Characterization of paediatric skeletal tumors and tumor-like conditions: specific cross-sectional imaging signs. Skeletal Radiol 2006; 35: 259-68.
12. Mori T, Fujii M, Akisue T, et al. Three-dimensional images of contrast-enhanced MDCT for preoperative assessment of musculoskeletal masses: comparison with MRI and plain radiographs. Radiat Med 2005; 23: 398-406.
13. Shin HJ, Amaral JG, Armstrong D, et al. Image-guided percutaneous biopsy of musculoskeletal lesions in children. Pediatr Radiol 2007; 37: 362-9.
14. Ma LD. Magnetic resonance imaging of musculoskeletal tumours: skeletal and soft tissue masses. Curr Probl Diagn Radiol 1999; 28: 33-62.
15. O'Donnell P, Saifuddin A. The prevalence and diagnostic significance of fluid-fluid levels in focal lesions of bone. Skeletal Radiol 2004; 33: 330-6.
16. Ilaslan H, Sundaram M. Advances in musculoskeletal tumor imaging. Orthop Clin North Am 2006; 37: 375-91.
17. Goo HW, Choi SH, Ghim T, et al. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 2005; 35: 766-73.
18. Mentzel HJ, Kentouche K, Sauner D, et al. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 2004; 14: 2297-302.
19. Costelloe CM, Kumar R, Yasko AW, et al. Imaging characteristics of locally recurrent tumors of bone. Am J Roentgenol 2007; 188: 855-63.
20. Teh J. Doppler imaging in the musculoskeletal system. In: McNally E. Practical Musculoskeletal Ultrasound. Philadelphia: Elsevier Churchill Livingstone, 2005; 277-80.
21. Iagaru A, Quon A, McDougall IR, Gambhir SS. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clin Nucl Med 2006; 31: 754-60.
22. Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology 2007; 243: 204-11.
23. Peabody TD, Simon MA. Making the diagnosis. Laboratory evaluation of pediatric bone and soft tissue tumors. Orthop Clin North Am 1996; 27: 453-9.
24. Kilpatrick SE, Cappellari JO, Bos GD, et al. Is fine needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients. Am J Clin Pathol 2001; 115: 59-68.
25. Kilpatrick SE, Ward WG, Cauvenet AR, Gold SH. The role of fine needle aspiration biopsy in the initial diagnosis of paediatric bone and soft tissue tumours: An institutional experience. Mod Pathol 1998; 11: 923-8.
26. Bennert KW, Abdul-Karim FW. Fine needle aspiration cytology vs needle core biopsy of soft tissue tumours; a comparison. Acta Cytol 1994; 38: 381-4.
27. Welker JA, Henshaw RM, Jelinek J, et al. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses: Outcomes analysis of 155 patients at a sarcoma referral centre. Cancer 2000; 89: 2677-81.
28. Willman JH, White K, Coffin CM. Paediatric core needle biopsy: Strengths and limitations in evaluation of masses. Pediatr Dev Pathol 2001; 4: 46-52.
29. Riepel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994; 25: 396-9.
30. Folpe AL, Hill CE, Parnham DM, et al. Immunohistochemical detection of sdFLI-1 protein expression: A study of 132 round cell tumours with emphasis of CD99-positive mimics of Ewings's sarcoma/primitive neuroectodermal tumour. Am J Surg Pathol 2004; 24: 1657-62.
31. Miettinen M, Chatten J, Paetau A, Stevenson A. Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol 1998; 22: 327-32.
32. Athanasou NA, Quinn J, Heryet A, et al. Effect of decalcification agents on the immunoreactivity of cellular antigens. J Clin Pathol 1987; 40: 874-8.
33. Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of FLI-1, a nuclear transcription factor distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol 2001; 25: 1061-6.
34. Hill DA, Pfeifer JD, Marley EF, et al. WT1 staining reliably differentiates desmosplastic small round cell tumour from Ewing sarcoma/primitive neuroectodermal tumour. Am J Clin Pathol 2000; 114: 345-53.
35. Hung J, Anderson R. p53: function, mutations and sarcomas. Acta Orthop Scand 1997; 68 (Suppl 273): 68-73.
36. Lonardo F, Ueda T, Huvos AG, Ladaryi M. p53 and MDM2 alterations in osteosaromas: Correlation with clinicopathologic features and proliferative rate. Cancer 1997; 79: 1541-7.
37. Creager AJ, Cohen JA, Geradts J. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia. Cancer Detect Prev 2001; 25: 123-31.
38. May WA, Lessnick SL, Braun BS, et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcription activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 1993; 13: 7393-8.
39. Zielenska M, Zhang ZM, Ng K, et al. Acquisition of secondary structural chromosomal changes in paediatric Ewing sarcoma is a probable prognostic factor for tumour response and clinical outcome. Cancer 2001; 91: 2156-64.
40. Thorner P, Squire J, Chilton-McNeill S, et al. Is the EWS/FLI-1 fusion transcript specific for Ewing's sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumour types. Am J Pathol 1996; 148: 1125-38.
41. Burchill SA, Wheeldon J, Cullinane C, Lewis IS. EWS-FLI-1 fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer 1997; 33: 239-43.
42. Sainati L, Scapinello A, Montaldi A, et al. A mesenchymal chondrosarcoma of a child with a reciprocal tanslocation (11;22) (q24;q12). Cancer Genet Cytogenet 1993; 71: 144-7.
43. Araki N, Uchida A, Kimura T, et al. Involvement of the retinoblastoma gene in primary osteosarcoma and other bone and soft-tissue tumors. Clin Orthop Relat Dis 1991; 270: 271-7.
44. Ueda Y, Dockhorn-Dworniczak B, Blasius S, et al. Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 1993; 119: 172-8.
45. Feugeas O, Guriec N, Babin-Boilletot A, et al. Loss of heterozygosity of the Rb gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 1996; 14: 467-72.
46. Miller CW, Aslo A, Won A, et al. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 1996; 122: 559-65.
47. Radland BD, Bell WC, Lopez RR, Siegel GP. Cytogenetics and molecular biology of osteosarcoma. Lab Invest 2002; 82: 365-73.
48. Van den Berg S, Rahmsdorg HJ, Herrlich P, Kaina B. Overexpression of c-fos increases recombination frequency in human osteosarcoma cells. Carcinogenesis 1993; 14: 925-8.
49. Kuroda T, Honna T, Morikawa N, et al. Tumour cells dynamics and metastasis in advanced neuroblastoma. Pediatr Surg Int 2005; 21: 943-6.
50. Lee PD, Noble-Topham SE, Bell RS, Andrulis IL. Quantitative analysis of multidrug resistance gene expression in human osteosarcomas. Br J Cancer 1996; 74: 1046-50.
51. Mankin H. Flow cytometry. In: Coombs R, Friedlander G. Bone Tumour Management. London: Butterworths, 1987; 68-70.
52. Roessner A, Grundmann. Electron microscopy in bone tumor diagnosis. Curr Top Pathol 1982; 71: 153-99.
53. th ed. Philadelphia: Lippincott-Raven, 1996.
54. Kozlowski K, Beluffi G, Cohen DH, et al. Primary bone tumours in infants: short literature review and report of 10 cases. Pediatr Radiol 1985; 15: 359-67.
55. Mirra JM. Tumors and tumorous conditions of the bones and joints. Philadelphia: Lea and Febiger, 1989.
56. Dorfman GD, Czerniak B. Bone Tumours. St Louis: Mosby, 1988.
57. Athanasou NA. Pathological Basis of Orthopaedic and Rheumatic Disease. London: Edward Arnold, 2001.
58. Klein MH, Shankman S. Osteoid osteoma. Radiologic and pathologic correlation. Skeletal Radiol 1992; 21: 23-31.
59. Frassica FJ, Waltrip RL, Sponseller PD, et al. Clinicopathological features and treatment of osteoblastoma and osteoid osteoma in children and adolescents. Orthop Clin North Am 1996; 27: 559-74.
60. Lucas DR, Unni KK, MeLeod RA, et al. Osteoblastoma. Clinicopathologic study of 306 cases. Hum Pathol 1994; 25: 117-34.
61. Theologis T, Ostlere S, Gibbons CLMH, Athanasou NA. Toxic osteoblastoma of the scapula. Skeletal Radiol 2007; 36: 253-7.
62. Dorfman HD, Weiss SW. Borderline osteoblastic tumours. Problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1984; 1: 215-34.
63. de Oliveira CR, Mendonça BB, de Camargo OP, et al. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters. Clinics 2007; 62: 167-74.
64. Klein MJ, Kenan S, Lewis MM. Osteosarcoma. Clinical and pathological considerations. Orthop Clin North Am 1989; 20: 327-45.
65. Ayala AG, Raymond AK, Jaffe N. The pathologist's role in the diagnosis and treatment of osteosarcoma in children. Hum Pathol 1984; 15: 258-66.
66. Mahoney JP, Spanier SS, Morris JL. Multifocal osteosarcoma. A case report with review of the literature. Cancer 1979; 44: 1897-907.
67. Parham DM, Pratt CB, Parvey LS, et al. Childhood multifocal osteosarcoma: Clinicopathologic and radiologic correlates. Cancer 1985; 55: 2653-8.
68. Sim FH, Unni KK, Beabout JW, et al. Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg 1979; 61A: 207-15.
69. Martin SE, Dwyer A, Kissane JM, Costa J. Small-cell osteosarcoma. Cancer 1982; 50: 990-6.
70. Hameed M. Small round cell tumors of bone. Arch Pathol Lab Med 2007; 131: 192-204.
71. Bertoni F, Bacchini P, Fabbri N, et al. Osteosarcoma. Low-grade intraosseous-type osteosarcoma histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer 1993; 71: 338-45.
72. Mirra JM, Gold R, Downs J, Eckardt JJ. A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathological analysis of 51 cases. Clin Orthop Relat Res 1985; 201: 214-37.
73. Bauer TW, Dorfman HD, Latham JT Jr. Periosteal chondroma. A clinicopathologic study of 23 cases. Am J Surg Pathol 1982; 6: 631-7.
74. Hopyan S, Gokgoz N, Poon R, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002; 30: 306-10.
75. Bovee JVMG, Hogendoorn PCW. Multiple osteochondromas. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and Genetics of Soft Tissue and Bone. Lyon: IARC Press, 2002; 360-2.
76. Keret D, Spatz DK, Caro P, Mason D. Dysplasia epiphysialis hemimelica. J Pediatr Orthop 1992; 12: 365-72.
77. Weiss AP, Dorfman HD. S-100 protein in human cartilage lesions. J Bone Joint Surg 1986; 68A: 521-6.
78. Sainati L, Scapinello A, Montaldi A, et al. A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12). Cancer Genet Cytogenet 1993; 71: 144-7.
79. Bjornsson J, Unni KK, Dahlin DC, et al. Clear cell chondrosarcoma of bone. Observations in 47 cases. Am J Surg Pathol 1984; 8: 223-30.
80. Capanna R, Bertoni F, Bettelli G, et al. Dedifferentiated chondrosarcoma. J Bone Joint Surg 1988; 70A: 60-9.
81. Schajowicz F. Juxtacortical chondrosarcoma. J Bone Joint Surg 1977; 59B: 473-80.
82. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws. A clinicopathologic study. J Oral Maxillofacial Surg 1986; 44: 708-13.
83. Wold LE, Dobyns JH, Swee RG, Dahlin DC. Giant cell reaction (giant cell reparative granuloma) of the small bones of the hands and feet. Am J Surg Pathol 1986; 10: 491-6.
84. Itonaga I, Hussein I, Kudo O, et al. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw. J Oral Pathol Med 2003; 32: 224-31.
85. Itonaga I, Schulze E, Burge PD, et al. Phenotypic characterisation of mononuclear and multinucleated cells of giant cell reparative granuloma of small bones. J Pathol 2002; 198: 30-6.
86. Roessner A, Jurgens H. Round cell tumors of bone. Pathol Res Pract 1993; 189: 111-36.
87. Ushigome S, Machinami R, Sorensen PH. Ewing sarcoma/primitive neuroectodermal tumors (PNET). In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and Genetics of Soft Tissue and Bone. Lyon: IARC Press, 2002; 298-300.
88. Eggli KD, Quiogue T, Moser RP Jr. Ewing's sarcoma. Radiol Clin North Am 1993; 31: 325-37.
89. Llombart-Bosch A, Lacombe MJ, Contesso G, Peydro-Olaya A. Small round blue cell sarcoma of bone mimicking atypical Ewing's sarcoma with neuroectodermal features. An analysis of five cases with immunohistochemical and electron microscopic support. Cancer 1987; 60: 1570-82.
90. Nascimento AG, Unni KK, Pritchard DJ, et al. A clinico-pathoologic study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone. Am J Surg Pathol 1980; 4: 29-36.
91. Ambros IM, Ambros PF, Strehl S, et al. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991; 67: 1886-93.
92. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1989; 25: 396-9.
93. Jaffe R, Santamaria M, Yunis EJ, et al. The neuroectodermal tumor of bone. Am J Surg Pathol 1984; 8: 885-98.
94. Ladanyl M, Heinemann FS, Huvos AG, et al. Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;12): an immunohistochemical study of 11 cases. Hum Pathol 1990; 21: 1245-51.
95. Clayton F, Butler JJ, Ayala AG, et al. Non-Hodgkin's lymphoma of bone. Pathologic and radiologic features with clinical correlates. Cancer 1987; 60: 2494-501.
96. Baar J, Burkes RL, Bell R, et al. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 1994; 73: 1194-9.
97. Parker BR, Marglin S, Castellino RA, et al. Skeletal manifestations of leukemia, Hodgkin disease, and non-Hodgkin lymphoma. Semin Roentgenol 1980; 15: 302-15.
98. Newcomer LN, Silverstein MB, Cadman EC, et al. Bone involvement in Hodgkin's disease. Cancer 1982; 49: 338-42.
99. Unni KK, Ivins JC, Beabout JW, Dahlin DC. Hemangioma hemangiopericytoma, and hemangioendothelioma (angiosarcoma) of bone. Cancer 1971; 27: 1403-14.
100. Wold LE, Swee RG, Sim FH. Vascular lesions of bone. Pathol Annu 1985; 20: 101-37.
101. Choma ND, Biscotti CV, Bauer TW, et al. Gorham's syndrome: a case report and review of the literature. Am J Med 1987; 83: 1151-6.
102. Fornasier VL. Haemangiomatosis with massive osteolysis. J Bone Joint Surg 1970; 52B: 444-51.
103. Edwards JR, Williams K, Kindblom LG, et al. Lymphatics and bone. Hum Pathol 2007; (in press).
104. Xu H, Edwards J, Espinosa O, et al. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumours. Hum Pathol 2004; 35: 857-61.
105. Boyle WJ. Cystic angiomatosis of bone. J Bone Joint Surg 1972; 54B: 626-36.
106. Moseley JE, Starobin SG. Cystic angiomatosis of bone. Manifestation of a hamartomatous disease entity. Am J Roentgenol Radium Ther Nucl Med 1964; 91: 1114-20.
107. Marks KE, Bauer TW. Fibrous tumors of bone. Orthop Clin North Am 1989; 20: 377-93.
108. Inwards CY, Unni KK, Beabout JW, Sim FH. Desmoplastic fibroma of bone. Cancer 1991; 68: 1978-83.
109. Rubin BP, Bridge JA. Myofibroma/myofibromatosis. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and Genetics of Soft Tissue and Bone. Lyon: IARC Press, 2002; 59-61.
110. Weiss SW, Goldblum JR. Soft Tissue Tumors. St Louis: Mosby, 2001.
111. Heiple KG, Perrin E, Aikawa M. Congenital generalized fibromatosis. A case limited to osseous lesions. J Bone Joint Surg 1972; 54A: 663-9.
112. Davies RS, Carty H, Pierro A. Infantile myofibromatosis. A review. Br J Radiol 1994; 67: 619-23.
113. Tarkkanen M, Kaipainen A, Karaharju E, et al. Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet 1993; 68: 1-21.
114. Mirra JM, Gold RH, Rand F. Disseminated nonossifying fibromas in association with café-au-lait spots (Jaffe-Campanacci syndrome). Clin Orthop Relat Dis 1982; 168: 192-205.
115. Evans GA, Park WM. Familial multiple non-osteogenic fibromata. J Bone Joint Surg 1978; 60B: 416-9.
116. Chigira M, Maehara S, Arita S, Udagawa E. The aetiology and treatment of simple bone cysts. J Bone Joint Surg 1983; 65B: 633-7.
117. Campanacci M, Capanna R, Picci P. Unicameral and aneurysmal bone cysts. Clin Orthop Relat Dis 1986; 204: 25-36.
118. Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer 1988; 61: 2291-304.
119. Vergel De Dios AM, Bond JR, Shives TC, et al. Aneurysmal bone cyst. A clinicopathologic study of 238 cases. Cancer 1992; 69: 2921-31.
120. Kransdorf MJ, Sweet DE. Aneurysmal bone cyst. Concept, controversy, clinical presentation, and imaging. Am J Roentgenol 1995; 164: 573-80.
121. Sanerkin NG, Mott MG, Roylance J. An unusual intraosseous lesion with fibroblastic, osteoclastic, osteoblastic, aneurysmal and fibromyxoid elements. 'Solid' variant of aneurysmal bone cyst. Cancer 1983; 51: 2278-86.
122. Sciot R, Dorfman H, Brys P, et al. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol 2000; 13: 1206-10.
123. Harris WH, Dudley HR Jr, Barry RJ. The natural history of fibrous dysplasia. J Bone Joint Surg 1962; 44A: 207-33.
124. Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in Albright-McCune-Sternberg syndrome. J Clin Endocrinol Metab 1994; 79: 750-5.
125. Alman BA, Greel DA, Wolfe HJ. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 1996; 14: 311-5.
126. Huvos AG, Higinbotham NL, Miller TR. Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg 1972; 54A: 1047-56.
127. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer 1994; 73: 1411-24.
128. Dahlin DC, Bertoni F, Beabout JW, Campanacci M. Fibrocartilaginous mesenchymoma with low-grade malignancy. Skeletal Radiol 1984; 12: 263-9.
129. Bulychova IV, Unni KK, Bertoni F, Beabout JW. Fibrocartilaginous mesenchymoma of bone. Am J Surg Pathol 1993; 17: 830-6.
130. Ishida T, Dorfman HD. Massive chondroid differentiation in fibrous dysplasia of bone (fibrocartilaginous dysplasia). Am J Surg Pathol 1993; 17: 924-30.
131. Park YK, Unni KK, McLeod RA, Pritchard DJ. Osteofibrous dysplasia. Clinicopathologic study of 80 cases. Hum Pathol 1993; 24: 1339-47.
132. Vigorita V, Ghelman B, Hogendoorn PCW. Osteofibrous dysplasia. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002; 343-4.
133. Ishida T, Iijima T, Kikuchi F, et al. A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 1992; 21: 493-502.
134. Benassi MS, Campanacci L, Gamberi G, et al. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis. Histopathology 1994; 25: 71-6.
135. McCarthy EF, Dorfman HD. Vascular and cartilaginous hamartoma of the ribs in infancy with secondary aneurysmal bone cyst formation. Am J Surg Pathol 1980; 4: 247-53.
136. Ayala AB, Ro JY, Bolio-Solis A, et al. Mesenchymal hamartoma of the chet wall in infants and children. A clinicopathological study of five patients. Skeletal Radiol 1993; 22: 469-576.
137. Kilpatrick SE, Wenger DE, Gilchrist GS, et al. Langerhans' cell histiocytosis (Histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995; 76: 2471-84.
138. Lieberman PH, Jones CR, Steinmann RM, et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996; 20: 519-52.
139. Risdall RJ, Dehner LP, Duray P, et al. Histiocytosis X (Langerhans cell histiocytosis). Prognostic role of histopathology. Arch Pathol Lab Med 1983; 107: 59-63.
140. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343: 767-8.
141. Leeson MC, Makley IT, Carter JR. Metastatic skeletal disease in the pediatric population. J Pediatric Orthop 1985; 5: 261-7.
142. Hope JW, Burns PF. Radiologic diagnosis of primary and metastatic cancer in infant and children. Radiol Clin North Am 1965; 3: 353-74.